» Articles » PMID: 28748512

Cross-cultural Adaptation and Validation of the Chinese Version of the Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S)

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2017 Jul 28
PMID 28748512
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The Health Assessment Questionnaire for Spondyloarthropathies (HAQ-S) is a commonly used questionnaire to evaluate function and health status of patients with ankylosing spondylitis (AS). The objective of this study was to cross-culturally adapt the HAQ-S into Chinese and then to evaluate its reliability and validity. The Chinese version of the HAQ-S was obtained with a five-step procedure of translation and cross-cultural adaptation. All invited patients met the New York criteria for AS, and a total of 103 patients finally participated in this study. Intraclass correlation coefficient (ICC) was used to evaluate the test-retest and inter-rater reliability of the HAQ-S. Internal consistency of the questionnaire was evaluated by Cronbach's alpha coefficient. Spearman's correlation coefficient was calculated to assess the construct validity between the HAQ-S and Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), Bath AS Metrology Index (BASMI), and the laboratory parameters (erythrocyte sedimentation rate, ESR; C-reactive protein, CRP). Test-retest and inter-rater reliability were excellent with intraclass correlation coefficients of 0.987 (p < 0.05) and 0.982 (p < 0.05), respectively. The overall internal consistency of the HAQ-S was found satisfactory (Cronbach's alpha = 0.914). The Chinese version of the HAQ-S correlated good with the BASFI (r = 0.749, p < 0.01), and moderate with the BASDAI (r = 0.581, p < 0.01) and the BASMI (r = 0.425, p < 0.01). But, the adapted questionnaire correlated poorly with ESR (r = 0.298, p < 0.01) or CRP (r = 0.283, p < 0.01). The Chinese version of the HAQ-S is reliable and valid for the evaluation of Chinese-speaking patients with AS.

Citing Articles

Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.

Su J, Li M, He L, Zhao D, Wan W, Liu Y Clin Rheumatol. 2021; 41(3):731-739.

PMID: 34709497 PMC: 8873115. DOI: 10.1007/s10067-021-05943-w.

References
1.
Zhang C, Liu D, Qu Y, Jia Z, Wang W, Li J . Transcultural adaptation and validation of the Chinese version of the intermittent and constant osteoarthritis pain (ICOAP) measure in patients with knee osteoarthritis. Osteoarthritis Cartilage. 2016; 25(4):506-512. DOI: 10.1016/j.joca.2016.11.012. View

2.
Guillemin F, Bombardier C, Beaton D . Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993; 46(12):1417-32. DOI: 10.1016/0895-4356(93)90142-n. View

3.
Mokkink L, Terwee C, Patrick D, Alonso J, Stratford P, Knol D . The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010; 19(4):539-49. PMC: 2852520. DOI: 10.1007/s11136-010-9606-8. View

4.
Calin A, Garrett S, Whitelock H, Kennedy L, OHea J, Mallorie P . A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994; 21(12):2281-5. View

5.
Bruce B, Fries J . The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol. 2005; 23(5 Suppl 39):S14-8. View